Glück Conviction Score™ ⓘ
RVMD
Revolution Medicines, Inc.
Effektiv: Neutral
Hoch
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
78,6
182 neu, 177 erhöht, 4053,3M $ netto
Aktivist
0,0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 141.50 | +8.7 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 92.76 | +65.9 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 150.12 | EMA50: 140.22 | |
| MACD-Histogramm | Bärisch | 10 % | -1.398 | Bearisch | |
| RSI(14) | Neutral | 10 % | 55.5 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 49.6 | Neutral | |
| ADX(14)+DI | Bullisch | 10 % | 27.4 | +DI: 24.1 / −DI: 18.6 | |
| Z-Score(60) | Neutral | 5 % | 0.85 | In Range | |
| 52W-Position | Bullisch | 5 % | 92.4 % | Hoch 163.68 / Tief 34.70 | |
| Bollinger(20,2σ) | Neutral | 5 % | 61.6 % | Upper 161.04 / Mid 151.71 / Lower 142.37 | |
| LinReg-Slope(60) | Bullisch | 10 % | +1.1201 | R²=0.68 / annualisiert +210.9 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -421 | 154,82 | -65.177,41 | -7,8% | |
| 2026-05-26 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -2.000 | 154,06 | -308.121,80 | -36,7% | |
| 2026-05-26 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -700 | 153,30 | -107.311,61 | -12,8% | |
| 2026-04-27 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -400 | 134,34 | -53.734,00 | -6,4% | |
| 2026-04-27 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -1.671 | 131,66 | -220.007,03 | -26,2% | |
| 2026-04-27 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -1.049 | 132,88 | -139.387,76 | -16,6% | |
| 2026-04-15 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -120.000 | 150,09 | -18.010.488,00 | -2142,5% | |
| 2026-03-25 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -21.086 | 95,49 | -2.013.415,69 | -239,5% | |
| 2026-03-25 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -11.036 | 96,43 | -1.064.200,38 | -126,6% | |
| 2026-03-25 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -400 | 97,21 | -38.882,84 | -4,6% | |
| 2026-03-25 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -3.128 | 94,16 | -294.520,28 | -35,0% | |
| 2026-03-25 | Mancini Anthony | Officer, See Remarks | Open Market Sale | -1.800 | 93,22 | -167.801,40 | -20,0% | |
| 2026-03-19 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -1.163 | 97,44 | -113.322,72 | -13,5% | |
| 2026-03-17 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -4.302 | 99,48 | -427.964,68 | -50,9% | |
| 2026-03-17 | Wang Xiaolin | Officer, See Remarks | Open Market Sale | -2.010 | 99,48 | -199.955,60 | -23,8% | |
| 2026-03-17 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -1.795 | 99,48 | -178.567,32 | -21,2% | |
| 2026-03-17 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -2.753 | 99,48 | -273.869,54 | -32,6% | |
| 2026-03-17 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -4.583 | 99,48 | -455.918,67 | -54,2% | |
| 2026-03-17 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -12.871 | 99,48 | -1.280.412,23 | -152,3% | |
| 2026-03-17 | Wei Lin | Officer, Chief Medical Officer | Open Market Sale | -2.073 | 99,48 | -206.222,87 | -24,5% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -100 | 98,29 | -9.829,00 | -1,2% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -21.329 | 101,60 | -2.167.075,46 | -257,8% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -3.620 | 100,73 | -364.659,25 | -43,4% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -3.500 | 99,76 | -349.150,20 | -41,5% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -2.100 | 101,63 | -213.431,61 | -25,4% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -1.700 | 101,47 | -172.506,31 | -20,5% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -851 | 102,20 | -86.971,69 | -10,3% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -800 | 102,00 | -81.598,64 | -9,7% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -700 | 98,17 | -68.719,56 | -8,2% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -600 | 100,19 | -60.115,98 | -7,2% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -400 | 100,12 | -40.049,00 | -4,8% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -200 | 102,08 | -20.416,00 | -2,4% | |
| 2026-03-02 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -100 | 98,31 | -9.831,00 | -1,2% | |
| 2026-01-21 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -908 | 115,60 | -104.964,80 | -12,5% | |
| 2026-01-07 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -1.700 | 102,90 | -174.930,00 | -20,8% | |
| 2026-01-07 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -20.204 | 101,79 | -2.056.621,73 | -244,7% | |
| 2026-01-07 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -53.096 | 100,02 | -5.310.470,77 | -631,7% | |
| 2026-01-07 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -10.000 | 98,00 | -980.000,00 | -116,6% | |
| 2025-12-16 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -2.688 | 76,82 | -206.483,83 | -24,6% | |
| 2025-12-16 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -5.447 | 76,82 | -418.423,29 | -49,8% | |
| 2025-12-16 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -15.394 | 76,82 | -1.182.525,52 | -140,7% | |
| 2025-12-16 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -4.847 | 76,82 | -372.333,45 | -44,3% | |
| 2025-12-16 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -3.104 | 77,09 | -239.288,60 | -28,5% | |
| 2025-11-25 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -3.000 | 75,00 | -225.000,00 | -26,8% | |
| 2025-11-25 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -60.000 | 75,08 | -4.504.962,00 | -535,9% | |
| 2025-11-25 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -5.418 | 74,00 | -400.932,00 | -47,7% | |
| 2025-11-18 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -20.000 | 70,38 | -1.407.586,00 | -167,4% | |
| 2025-11-18 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -13.388 | 70,14 | -939.007,54 | -111,7% | |
| 2025-11-12 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -20.000 | 65,07 | -1.301.410,00 | -154,8% | |
| 2025-11-11 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -10.000 | 64,00 | -640.000,00 | -76,1% | |
| 2025-11-07 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -30.000 | 60,31 | -1.809.306,00 | -215,2% | |
| 2025-10-17 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -12.000 | 55,00 | -660.000,00 | -78,5% | |
| 2025-10-17 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -10.000 | 55,00 | -550.000,00 | -65,4% | |
| 2025-10-16 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -10.000 | 50,47 | -504.701,00 | -60,0% | |
| 2025-10-13 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -25.000 | 48,54 | -1.213.540,00 | -144,4% | |
| 2025-09-24 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -1.799 | 44,26 | -79.623,74 | -9,5% | |
| 2025-09-16 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -5.367 | 45,82 | -245.942,24 | -29,3% | |
| 2025-09-16 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -2.320 | 45,82 | -106.313,77 | -12,6% | |
| 2025-09-16 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -1.869 | 45,82 | -85.646,74 | -10,2% | |
| 2025-09-16 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -4.775 | 45,82 | -218.813,90 | -26,0% | |
| 2025-09-16 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -13.411 | 45,82 | -614.557,73 | -73,1% | |
| 2025-09-16 | Wei Lin | Officer, Chief Medical Officer | Open Market Sale | -2.160 | 45,82 | -98.981,78 | -11,8% | |
| 2025-09-15 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -23.682 | 45,92 | -1.087.418,24 | -129,4% | |
| 2025-09-15 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -1.318 | 46,93 | -61.854,00 | -7,4% | |
| 2025-09-11 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -44.059 | 43,58 | -1.919.963,45 | -228,4% | |
| 2025-09-11 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -55.941 | 44,48 | -2.488.518,60 | -296,0% | |
| 2025-09-03 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -5.238 | 40,17 | -210.432,46 | -25,0% | |
| 2025-09-02 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -4.762 | 40,02 | -190.560,00 | -22,7% | |
| 2025-06-20 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -1.912 | 39,61 | -75.735,85 | -9,0% | |
| 2025-06-16 | Wei Lin | Officer, Chief Medical Officer | Open Market Sale | -2.173 | 39,83 | -86.550,59 | -10,3% | |
| 2025-06-16 | Kelsey Stephen Michael | Officer, See Remarks | Open Market Sale | -4.289 | 39,83 | -170.830,87 | -20,3% | |
| 2025-06-16 | Anders Jack | Officer, Chief Financial Officer | Open Market Sale | -2.170 | 39,83 | -86.431,10 | -10,3% | |
| 2025-06-16 | Cislini Jeff | Officer, General Counsel | Open Market Sale | -1.878 | 39,83 | -74.800,74 | -8,9% | |
| 2025-06-16 | GOLDSMITH MARK A | Director, Officer, See Remarks | Open Market Sale | -13.496 | 39,83 | -537.545,68 | -63,9% | |
| 2025-06-16 | Horn Margaret A | Officer, Chief Operating Officer | Open Market Sale | -3.510 | 39,83 | -139.803,30 | -16,6% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 16.719.886 | 0 | 16.719.886 | 1.331.738.920 | Neu | +100,0% | |
| FARALLON CAPITAL MANAGEMENT LLC | 13.724.881 | 0 | 13.724.881 | 1.323.275.359 | Neu | +100,0% | |
| BlackRock, Inc. | 11.212.706 | 8.926.656 | 2.286.050 | 1.090.435.565 | Aufgestockt | +25,6% | |
| JANUS HENDERSON GROUP PLC | 9.766.496 | 12.303.502 | -2.537.006 | 949.537.126 | Reduziert | -20,6% | |
| BAKER BROS. ADVISORS LP | 9.555.357 | 9.455.357 | 100.000 | 929.258.468 | Aufgestockt | +1,1% | |
| FMR LLC | 8.464.314 | 8.587.981 | -123.667 | 823.154.497 | Reduziert | -1,4% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.362.284 | 0 | 8.362.284 | 813.232.119 | Neu | +100,0% | |
| Nextech Invest, Ltd. | 7.601.087 | 7.601.087 | 0 | 739.205.711 | Unverändert | 0,0% | |
| Paradigm Biocapital Advisors LP | 6.655.703 | 6.644.403 | 11.300 | 647.267.117 | Aufgestockt | +0,2% | |
| WELLINGTON MANAGEMENT GROUP LLP | 6.027.819 | 6.987.639 | -959.820 | 586.205.399 | Reduziert | -13,7% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.975.611 | 2.705.555 | 3.270.056 | 533.398.170 | Aufgestockt | +120,9% | |
| STATE STREET CORP | 4.402.662 | 4.109.290 | 293.372 | 428.158.880 | Aufgestockt | +7,1% | |
| UBS Group AG | 4.395.177 | 3.087.937 | 1.307.240 | 427.346.386 | Aufgestockt | +42,3% | |
| GEODE CAPITAL MANAGEMENT, LLC | 3.338.142 | 3.161.963 | 176.179 | 323.930.219 | Aufgestockt | +5,6% | |
| Alphabet Inc. | 3.292.525 | 3.345.102 | -52.577 | 320.198.056 | Reduziert | -1,6% | |
| BVF INC/IL | 2.856.782 | 3.356.782 | -500.000 | 277.822.050 | Reduziert | -14,9% | |
| Integral Health Asset Management, LLC | 2.750.000 | 1.200.000 | 1.550.000 | 267.437.500 | Aufgestockt | +129,2% | |
| Casdin Capital, LLC | 2.577.333 | 2.577.333 | 0 | 250.645.634 | Unverändert | 0,0% | |
| Woodline Partners LP | 2.506.570 | 2.500.895 | 5.675 | 243.763.933 | Aufgestockt | +0,2% | |
| Holocene Advisors, LP | 2.468.644 | 1.907.948 | 560.696 | 240.075.629 | Aufgestockt | +29,4% | |
| Vestal Point Capital, LP | 2.375.000 | 295.000 | 2.080.000 | 230.968.750 | Aufgestockt | +705,1% | |
| Avoro Capital Advisors LLC | 2.344.444 | 2.170.000 | 174.444 | 227.997.179 | Aufgestockt | +8,0% | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.297.000 | 2.894.613 | -597.613 | 223.383.250 | Reduziert | -20,6% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2.229.085 | 1.248.038 | 981.047 | 216.778.516 | Aufgestockt | +78,6% | |
| GOLDMAN SACHS GROUP INC | 2.185.500 | 2.533.583 | -348.083 | 212.539.875 | Reduziert | -13,7% | |
| Darwin Global Management, Ltd. | 2.211.018 | 0 | 2.211.018 | 204.983.479 | Neu | +100,0% | |
| NORGES BANK | 2.455.347 | 0 | 2.455.347 | 195.568.389 | Neu | +100,0% | |
| Logos Global Management LP | 2.000.000 | 3.000.000 | -1.000.000 | 194.500.000 | Reduziert | -33,3% | |
| Alyeska Investment Group, L.P. | 1.885.821 | 239.097 | 1.646.724 | 183.396.092 | Aufgestockt | +688,7% | |
| Caligan Partners LP | 1.881.708 | 1.283.900 | 597.808 | 182.996.103 | Aufgestockt | +46,6% | |
| NATIONAL BANK OF CANADA /FI/ | 1.749.000 | 0 | 1.749.000 | 170.090.250 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.735.476 | 1.683.729 | 51.747 | 168.775.041 | Aufgestockt | +3,1% | |
| AMERIPRISE FINANCIAL INC | 1.579.793 | 2.056.857 | -477.064 | 153.635.129 | Reduziert | -23,2% | |
| Caption Management, LLC | 2.067.685 | 836.100 | 1.231.585 | 151.664.156 | Aufgestockt | +147,3% | |
| TWO SIGMA INVESTMENTS, LP | 1.558.807 | 421.735 | 1.137.072 | 151.593.981 | Aufgestockt | +269,6% | |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.556.578 | 2.845.013 | -1.288.435 | 151.377.191 | Reduziert | -45,3% | |
| Bellevue Group AG | 1.544.456 | 5.005.719 | -3.461.263 | 150.198.346 | Reduziert | -69,1% | |
| Rock Springs Capital Management LP | 1.209.465 | 1.335.270 | -125.805 | 117.620.471 | Reduziert | -9,4% | |
| Polar Capital Holdings Plc | 1.133.930 | 2.013.791 | -879.861 | 110.274.693 | Reduziert | -43,7% | |
| FRANKLIN RESOURCES INC | 1.133.546 | 1.060.171 | 73.375 | 110.237.382 | Aufgestockt | +6,9% | |
| Siren, L.L.C. | 1.110.980 | 1.335.075 | -224.095 | 108.042.805 | Reduziert | -16,8% | |
| D. E. Shaw & Co., Inc. | 2.658.843 | 3.068.625 | -409.782 | 107.633.731 | Reduziert | -13,4% | |
| CITADEL ADVISORS LLC | 1.004.453 | 1.438.761 | -434.308 | 97.683.055 | Reduziert | -30,2% | |
| NORTHERN TRUST CORP | 954.256 | 850.323 | 103.933 | 92.801.396 | Aufgestockt | +12,2% | |
| a16z Capital Management, L.L.C. | 921.099 | 921.099 | 0 | 89.576.878 | Unverändert | 0,0% | |
| BOOTHBAY FUND MANAGEMENT, LLC | 850.795 | 353.552 | 497.243 | 82.739.814 | Aufgestockt | +140,6% | |
| DIMENSIONAL FUND ADVISORS LP | 844.614 | 1.161.646 | -317.032 | 82.072.300 | Reduziert | -27,3% | |
| AIHC Capital Management Ltd | 828.974 | 900.392 | -71.418 | 80.617.722 | Reduziert | -7,9% | |
| MIC Capital Management UK LLP | 795.733 | 508.569 | 287.164 | 77.385.034 | Aufgestockt | +56,5% | |
| Hood River Capital Management LLC | 945.585 | 0 | 945.585 | 75.315.845 | Neu | +100,0% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 13.724.881 | 0 | +100,0% | 1.323.275.359 | 7,16 |
| BlackRock, Inc. | 11.212.706 | 8.926.656 | +25,6% | 1.090.435.565 | 5,90 |
| JANUS HENDERSON GROUP PLC | 9.766.496 | 12.303.502 | -20,6% | 949.537.126 | 5,14 |
| BAKER BROS. ADVISORS LP | 9.555.357 | 9.455.357 | +1,1% | 929.258.468 | 5,03 |
| FMR LLC | 8.464.314 | 8.587.981 | -1,4% | 823.154.497 | 4,46 |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.362.284 | 0 | +100,0% | 813.232.119 | 4,40 |
| Nextech Invest, Ltd. | 7.601.087 | 7.601.087 | 0,0% | 739.205.711 | 4,00 |
| Paradigm Biocapital Advisors LP | 6.655.703 | 6.644.403 | +0,2% | 647.267.117 | 3,50 |
| WELLINGTON MANAGEMENT GROUP LLP | 6.027.819 | 6.987.639 | -13,7% | 586.205.399 | 3,17 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5.975.611 | 2.705.555 | +120,9% | 533.398.170 | 2,89 |
| STATE STREET CORP | 4.402.662 | 4.109.290 | +7,1% | 428.158.880 | 2,32 |
| UBS Group AG | 4.395.177 | 3.087.937 | +42,3% | 427.346.386 | 2,31 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.338.142 | 3.161.963 | +5,6% | 323.930.219 | 1,75 |
| Alphabet Inc. | 3.292.525 | 3.345.102 | -1,6% | 320.198.056 | 1,73 |
| BVF INC/IL | 2.856.782 | 3.356.782 | -14,9% | 277.822.050 | 1,50 |
| Integral Health Asset Management, LLC | 2.750.000 | 1.200.000 | +129,2% | 267.437.500 | 1,45 |
| Casdin Capital, LLC | 2.577.333 | 2.577.333 | 0,0% | 250.645.634 | 1,36 |
| Woodline Partners LP | 2.506.570 | 2.500.895 | +0,2% | 243.763.933 | 1,32 |
| Holocene Advisors, LP | 2.468.644 | 1.907.948 | +29,4% | 240.075.629 | 1,30 |
| Vestal Point Capital, LP | 2.375.000 | 295.000 | +705,1% | 230.968.750 | 1,25 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 521 | 238,5 | 21.448 |
| 31.12.2025 | ✓ | 394 | 219,6 | 16.127 |
| 30.09.2025 | ✓ | 337 | 226,4 | 9.720 |
| 30.06.2025 | ✓ | 314 | 202,0 | 6.711 |
| 31.03.2025 | ✓ | 297 | 210,8 | 6.888 |
| 31.12.2024 | ✓ | 289 | 196,2 | 7.852 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| NORGES BANK | 2.455.347 | 195.568.389 |
| Avoro Capital Advisors LLC | 2.170.000 | 172.840.500 |
| AIHC Capital Management Ltd | 900.392 | 71.716.223 |
| Point72 Asset Management, L.P. | 446.616 | 35.572.964 |
| Defilade Capital Management, L.P. | 363.454 | 28.949.111 |
| Mass General Brigham, Inc | 344.091 | 27.406.848 |
| JENNISON ASSOCIATES LLC | 305.260 | 24.313.959 |
| Alyeska Investment Group, L.P. | 239.097 | 19.044.076 |
| MARSICO CAPITAL MANAGEMENT LLC | 219.460 | 17.479.989 |
| BAILLIE GIFFORD & CO | 194.959 | 15.528.484 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| UBS Group AG | 3.087.937 | 1.998.972 | +183.6 % | 245.954.181 |
| GOLDMAN SACHS GROUP INC | 2.533.583 | 1.753.557 | +224.8 % | 201.799.886 |
| Polar Capital Holdings Plc | 2.013.791 | 1.535.686 | +321.2 % | 160.398.453 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.705.555 | 1.463.155 | +117.8 % | 176.142.406 |
| Jefferies Financial Group Inc. | 1.141.195 | 1.128.195 | +8678.4 % | 90.896.182 |
| VANGUARD GROUP INC | 16.719.886 | 1.056.792 | +6.7 % | 1.331.738.920 |
| JANUS HENDERSON GROUP PLC | 12.303.502 | 947.448 | +8.3 % | 980.035.989 |
| AMERIPRISE FINANCIAL INC | 2.056.857 | 832.098 | +67.9 % | 163.828.755 |
| D. E. Shaw & Co., Inc. | 3.068.625 | 801.451 | +35.4 % | 129.901.051 |
| Integral Health Asset Management, LLC | 1.200.000 | 800.000 | +200.0 % | 95.580.000 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 6.987.639 | -2.825.797 | -28.8 % | 556.565.446 |
| T. Rowe Price Investment Management, Inc. | 2.200.376 | -2.581.942 | -54.0 % | 175.260 |
| JPMORGAN CHASE & CO | 421.627 | -2.076.700 | -83.1 % | 33.582.592 |
| a16z Capital Management, L.L.C. | 921.099 | -1.827.424 | -66.5 % | 73.365.535 |
| Holocene Advisors, LP | 1.907.948 | -1.529.335 | -44.5 % | 151.968.058 |
| STATE STREET CORP | 4.109.290 | -1.145.349 | -21.8 % | 327.304.949 |
| FMR LLC | 8.587.981 | -813.706 | -8.7 % | 684.032.699 |
| Alphabet Inc. | 3.345.102 | -788.175 | -19.1 % | 266.437.374 |
| MORGAN STANLEY | 651.732 | -782.910 | -54.6 % | 51.910.527 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.894.613 | -755.729 | -20.7 % | 230.555.925 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 15.05.2026 | JANUS HENDERSON GROUP PLC | Passiv (13G/A) | 4,90 % | 9.766.496 | -1,20 pp | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -8,93 pp | |
| 17.02.2026 | Baker Bros. Advisors (GP) LLC | Passiv (13G/A) | 4,90 % | 9.455.357 | -0,10 pp | |
| 17.02.2026 | Felix J. Baker | Passiv (13G/A) | 4,90 % | 9.455.357 | -0,10 pp | |
| 17.02.2026 | Baker Bros. Advisors LP | Passiv (13G/A) | 4,90 % | 9.455.357 | -0,10 pp | |
| 17.02.2026 | Julian C. Baker | Passiv (13G/A) | 4,90 % | 9.455.357 | -0,10 pp | |
| 10.02.2026 | Wellington Investment Advisors Holdings LLP | Passiv (13G/A) | 3,60 % | 6.987.639 | -1,90 pp | |
| 10.02.2026 | Wellington Management Group LLP | Passiv (13G/A) | 3,60 % | 6.987.639 | -1,90 pp | |
| 10.02.2026 | Wellington Group Holdings LLP | Passiv (13G/A) | 3,60 % | 6.987.639 | -1,90 pp | |
| 09.02.2026 | Spokes, Andrew J. M. | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Kim, David T. | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Farallon Capital Partners, L.P. | Passiv (13G/A) | 0,50 % | 1.057.562 | 0,00 pp | |
| 09.02.2026 | Patel, Rajiv A. | Passiv (13G/A) | Ausstieg | 0 | -7,90 pp | |
| 09.02.2026 | Roberts, Jr., Thomas G. | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Linn, Michael G. | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Saito Edric C. | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Farallon Capital Institutional Partners II, L.P. | Passiv (13G/A) | 0,20 % | 332.755 | 0,00 pp | |
| 09.02.2026 | Farallon Capital Offshore Investors II, L.P. | Passiv (13G/A) | 1,30 % | 2.482.796 | 0,00 pp | |
| 09.02.2026 | Farallon Capital (AM) Investors, L.P. | Passiv (13G/A) | 0,10 % | 151.742 | 0,00 pp | |
| 09.02.2026 | Seybold, William | Passiv (13G/A) | Ausstieg | 0 | -7,90 pp | |
| 09.02.2026 | Wehrly, Mark C. | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Dunn Hannah E. | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Giauque, Nicolas | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Gehani, Varun N. | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Farallon F5 (GP), L.L.C. | Passiv (13G/A) | 0,20 % | 370.466 | -0,10 pp | |
| 09.02.2026 | Dapice Joshua J. | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Husen, Avner A. | Passiv (13G/A) | 7,50 % | 14.596.149 | Neu | |
| 09.02.2026 | Farallon Healthcare Partners Master, L.P. | Passiv (13G/A) | 4,40 % | 8.420.065 | -0,30 pp | |
| 09.02.2026 | Luo Patrick (Cheng) | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Farallon Partners, L.L.C. | Passiv (13G/A) | 7,40 % | 14.225.683 | -0,20 pp | |
| 09.02.2026 | Four Crossings Institutional Partners V, L.P. | Passiv (13G/A) | 0,10 % | 238.987 | 0,00 pp | |
| 09.02.2026 | Farallon Capital F5 Master I, L.P. | Passiv (13G/A) | 0,20 % | 370.466 | -0,10 pp | |
| 09.02.2026 | Farallon Capital Institutional Partners, L.P. | Passiv (13G/A) | 0,70 % | 1.377.579 | 0,00 pp | |
| 09.02.2026 | Farallon Institutional (GP) V, L.L.C. | Passiv (13G/A) | 0,10 % | 238.987 | 0,00 pp | |
| 09.02.2026 | Fried, Richard B | Passiv (13G/A) | Ausstieg | 0 | -7,90 pp | |
| 09.02.2026 | Farallon Healthcare Partners (GP), L.L.C. | Passiv (13G/A) | 4,40 % | 8.420.065 | -0,30 pp | |
| 09.02.2026 | Farallon Capital Institutional Partners III, L.P. | Passiv (13G/A) | 0,10 % | 164.197 | 0,00 pp | |
| 09.02.2026 | Dreyfuss, Philip D. | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Short Daniel S. | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp | |
| 09.02.2026 | Warren, John R. | Passiv (13G/A) | 7,50 % | 14.596.149 | -0,40 pp |
Stammdaten
Revolution Medicines, Inc., ein klinisches Präzisions-Onkologie-Unternehmen, konzentriert sich auf die Entwicklung von Therapien zur Hemmung von Frontier-Zielen in RAS-abhängigen Krebsarten. Das Unternehmen entwickelt RMC-4630, einen Inhibitor von SHP2, der sich in einer Phase 1/2 klinischen Studie zur Behandlung von Festkörpertumoren, wie gynäkologischen und kolorektalen Krebstumoren, befindet. Es entwickelt auch RMC-5845, einen selektiven Inhibitor von SOS1, einem Protein, das RAS (OFF) zu RAS (ON) in Zellen umwandelt; und RMC-5552, einen hyperaktivierten selektiven Inhibitor der mTORC1-Signalisierung in Tumoren. Darüber hinaus entwickelt das Unternehmen RMC-6291, einen mutantenselektiven Inhibitor von KRASG12C(ON) und NRASG12C(ON); und RMC-6236, einen RAS-selektiven Inhibitor mehrerer RAS(ON)-Varianten. Weiterhin entwickelt es RAS(ON)-Inhibitoren, die auf KRASG13C(ON) und KRASG12D(ON) abzielen. Das Unternehmen hat eine Kooperationsvereinbarung mit Sanofi für die Forschung und Entwicklung von SHP2-Inhibitoren, einschließlich RMC-4630. Revolution Medicines, Inc. wurde 2014 gegründet und hat seinen Sitz in Redwood City, Kalifornien.
Unternehmen & Branche
| Name | Revolution Medicines, Inc. |
|---|---|
| Ticker | RVMD |
| CIK | 0001628171 |
| Boerse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 76155X100 |
|---|---|
| ISIN | US76155X1000 |
| Typ | Common Stock |
| Marktkapitalisierung | 29,40 Mrd. USD |
| Beta | 1,40 |
Bewertung
| KBV (P/B) | 18,02 vs. 3,10 (2021) ▲ |
|---|---|
| FCF-Rendite | -3,1 % vs. -8,2 % (2021) ▲ |
Qualität & Bilanz
| ROIC | -63,2 % vs. -28,0 % (2021) ▼ |
|---|---|
| Zinsdeckungsgrad | -48,8 |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 3,10 | 3,14 | 2,59 | 3,59 | 9,62 | |
| KUV (P/S) | 63,50 | 60,87 | 407,85 | – | – | |
| FCF-Rendite | -8,2 % | -10,9 % | -7,6 % | -7,0 % | -5,8 % | |
| Qualität & Bilanz | ||||||
| Operative Marge | -639,7 % | -730,0 % | -4.207,1 % | – | – | |
| Nettomarge | -636,6 % | -703,0 % | -3.768,3 % | – | – | |
| ROIC | -28,0 % | -33,2 % | -22,8 % | -25,0 % | -63,2 % | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | -453.816.000 | -2,29 | 2.253.737.000 | 1.499.917.000 | |
| 2025-12-31 | 10-K | 0 | -1.131.301.000 | -5,95 | 2.354.508.000 | 1.631.297.000 |
| 2025-09-30 | 10-Q | -305.206.000 | -1,61 | 2.251.920.000 | 1.596.904.000 | |
| 2025-06-30 | 10-Q | -247.787.000 | -1,31 | 2.429.568.000 | 1.865.369.000 | |
| 2025-03-31 | 10-Q | -213.416.000 | -1,13 | 2.365.353.000 | 2.078.150.000 | |
| 2024-12-31 | 10-K | 0 | -600.093.000 | -3,58 | 2.558.301.000 | 2.265.204.000 |
| 2024-09-30 | 10-Q | 0 | -156.288.000 | -0,94 | 1.762.999.000 | 1.566.304.000 |
| 2024-06-30 | 10-Q | 0 | -133.233.000 | -0,81 | 1.808.437.000 | 1.618.848.000 |
| 2024-03-31 | 10-Q | 0 | -116.003.000 | -0,70 | 1.908.362.000 | 1.725.467.000 |
| 2023-12-31 | 10-K | 11.580.000 | -436.367.000 | -3,86 | 2.061.705.000 | 1.826.194.000 |
| 2023-09-30 | 10-Q | 0 | -108.434.000 | -0,99 | 984.232.000 | 837.458.000 |
| 2023-06-30 | 10-Q | 3.824.000 | -98.298.000 | -0,92 | 1.073.709.000 | 930.835.000 |
| 2023-03-31 | 10-Q | 7.014.000 | -68.098.000 | -0,72 | 1.073.248.000 | 952.218.000 |
| 2022-12-31 | 10-K | 35.380.000 | -248.705.000 | -3,08 | 811.930.000 | 685.188.000 |
| 2022-09-30 | 10-Q | 3.356.000 | -73.329.000 | -0,87 | 825.910.000 | 681.419.000 |
| 2022-06-30 | 10-Q | 9.116.000 | -61.222.000 | -0,82 | 632.802.000 | 498.841.000 |
| 2022-03-31 | 10-Q | 7.578.000 | -57.647.000 | -0,78 | 682.774.000 | 550.993.000 |
| 2021-12-31 | 10-K | 29.390.000 | -187.091.000 | -2,57 | 737.988.000 | 602.568.000 |
| 2021-09-30 | 10-Q | 1.101.000 | -52.940.000 | -0,72 | 734.976.000 | 638.204.000 |
| 2021-06-30 | 10-Q | 8.698.000 | -44.299.000 | -0,60 | 774.046.000 | 685.006.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2022 | FY 2021 | FY 2020 | FY 2019 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Collaboration Revenue | 35,4 Mio. | 29,4 Mio. | 43,0 Mio. | 50,0 Mio. | 100,0 % | +20,4% |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 06.05.2026 | – | -2,29 |
| Q3 2025 | 30.09.2025 | 05.11.2025 | – | -1,61 |
| Q2 2025 | 30.06.2025 | 05.11.2025 | – | -1,31 |
| Q1 2025 | 31.03.2025 | 06.05.2026 | – | -1,13 |
| Q3 2024 | 30.09.2024 | 05.11.2025 | 0 USD | -0,94 |
| Q2 2024 | 30.06.2024 | 05.11.2025 | 0 USD | -0,81 |
| Q1 2024 | 31.03.2024 | 05.11.2025 | 0 USD | -0,70 |
| Q3 2023 | 30.09.2023 | 06.11.2024 | 0 USD | -0,99 |
| Q2 2023 | 30.06.2023 | 06.11.2024 | 3,8 Mio. USD | -0,92 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 06.05.2026 | 10-Q | 31.03.2026 | 36 Tage | SEC » |
| 25.02.2026 | 10-K | 31.12.2025 | 56 Tage | SEC » |
| 05.11.2025 | 10-Q | 30.09.2025 | 36 Tage | SEC » |
| 06.08.2025 | 10-Q | 30.06.2025 | 37 Tage | SEC » |
| 07.05.2025 | 10-Q | 31.03.2025 | 37 Tage | SEC » |
| 26.02.2025 | 10-K | 31.12.2024 | 57 Tage | SEC » |
| 06.11.2024 | 10-Q | 30.09.2024 | 37 Tage | SEC » |
| 07.08.2024 | 10-Q | 30.06.2024 | 38 Tage | SEC » |
| 08.05.2024 | 10-Q | 31.03.2024 | 38 Tage | SEC » |
| 26.02.2024 | 10-K | 31.12.2023 | 57 Tage | SEC » |
| 06.11.2023 | 10-Q | 30.09.2023 | 37 Tage | SEC » |
| 08.08.2023 | 10-Q | 30.06.2023 | 39 Tage | SEC » |
| 08.05.2023 | 10-Q | 31.03.2023 | 38 Tage | SEC » |
| 27.02.2023 | 10-K | 31.12.2022 | 58 Tage | SEC » |
| 07.11.2022 | 10-Q | 30.09.2022 | 38 Tage | SEC » |
| 09.08.2022 | 10-Q | 30.06.2022 | 40 Tage | SEC » |
| 09.05.2022 | 10-Q | 31.03.2022 | 39 Tage | SEC » |
| 28.02.2022 | 10-K | 31.12.2021 | 59 Tage | SEC » |
| 10.11.2021 | 10-Q | 30.09.2021 | 41 Tage | SEC » |
| 11.08.2021 | 10-Q | 30.06.2021 | 42 Tage | SEC » |
| 10.05.2021 | 10-Q | 31.03.2021 | 40 Tage | SEC » |
| 02.03.2021 | 10-K | 31.12.2020 | 61 Tage | SEC » |
| 12.11.2020 | 10-Q | 30.09.2020 | 43 Tage | SEC » |
| 10.08.2020 | 10-Q | 30.06.2020 | 41 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 08.03.2021 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02(f) of Form 8-K, the table below updates the “Non-equity incentive plan compensation” and… |
| 20.03.2020 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02(f) of Form 8-K, the table below updates the “Non-equity incentive plan compensation” and… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-13 | 194 | 145,72 | 28.270 |
| 2026-05-05 | 5.713 | 147,90 | 844.953 |
| 2026-04-23 | 496 | 141,50 | 70.184 |
| 2026-04-21 | 1 | 146,23 | 146 |
| 2026-04-20 | 2.345 | 148,63 | 348.537 |
| 2026-04-16 | 10 | 152,54 | 1.525 |
| 2026-04-15 | 3.375 | 147,01 | 496.159 |
| 2026-04-02 | 1 | 98,64 | 99 |
| 2026-03-25 | 252.389 | 95,52 | 24.108.197 |
| 2026-03-20 | 1.324 | 99,29 | 131.460 |
| 2026-03-12 | 48.958 | 99,59 | 4.875.727 |
| 2026-03-05 | 1.937 | 101,19 | 196.005 |
| 2026-02-23 | 12 | 101,83 | 1.222 |
| 2026-02-20 | 35.325 | 102,74 | 3.629.291 |
| 2026-02-19 | 35.325 | 99,79 | 3.525.082 |
| 2026-02-18 | 10 | 100,61 | 1.006 |
| 2026-02-11 | 31.194 | 95,98 | 2.994.000 |
| 2026-02-09 | 1 | 97,49 | 97 |
| 2026-02-02 | 99.786 | 96,95 | 9.674.253 |
| 2026-01-30 | 99.785 | 98,20 | 9.798.887 |
| 2026-01-29 | 99.673 | 97,33 | 9.701.173 |
| 2026-01-20 | 200 | 120,28 | 24.056 |
| 2026-01-16 | 6.119 | 123,27 | 754.289 |
| 2026-01-08 | 8.012 | 102,71 | 822.913 |
| 2026-01-06 | 10 | 78,33 | 783 |
| 2026-01-02 | 14.917 | 79,65 | 1.188.139 |
| 2025-12-29 | 10 | 80,75 | 808 |
| 2025-12-22 | 308 | 78,78 | 24.264 |
| 2025-12-18 | 33 | 76,74 | 2.532 |
| 2025-12-15 | 35 | 78,92 | 2.762 |